SEC Form 4 · accession 0001209191-17-057840
bluebird bio, Inc. · BLUE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nick Leschly
Officer — President and CEO · Director
Period of report
Oct 20, 2017
Accepted (ET)
Oct 24, 2017 · 4:17 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001293971
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Oct 20, 2017 | S | 3,350 | $145.0187 | D | 259,059 | D | |
| Common StockF3 | Oct 23, 2017 | S | 3,700 | $145.2581 | D | 255,359 | D | |
| Common Stock | holding | — | — | — | 17,186 | I | Nick Leschly 2001 Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 22, 2016.
- F2The range of prices for the transaction reported on this line was $145.00 to $145.15. The average weighted price was $145.0187. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F3The range of prices for the transaction reported on this line was $145.00 to $145.60. The average weighted price was $145.2581. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.